Spero Therapeutics, Inc. (SPRO)
2.42
+0.12
(+5.22%)
USD |
NASDAQ |
Feb 06, 16:00
2.395
-0.02
(-1.03%)
After-Hours: 20:00
Spero Therapeutics SG&A Expense (TTM) : 23.93M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| BioMarin Pharmaceutical, Inc. | 973.41M |
| Amicus Therapeutics, Inc. | 353.07M |
| Cassava Sciences, Inc. | 68.06M |
| Omeros Corp. | 44.20M |
| GeoVax Labs, Inc. | 6.16M |